... novel products will increase the product offering on the market, however, with only a fraction of the patient pool market receiving asthma treatment, considerable untapped patient potential will remain. Scope Access Datamonitor’s patient-based asthma market ...  |  read more...

... remain constant, although the total number of cases will increase as a result of the aging population and increasing urbanization. Introduction Gain insight into market potential, including a robust 10-year epidemiology forecast of prevalent asthma ...  |  read more...

... more used for hypertriglyceridemia. Traditional Chinese medicines are the second most popular choice to treat hypercholesterolemia. Features and benefits Follow patient segmentation and treatment pathways for dyslipidemia in China. Gain insight into the most commonly ...  |  read more...

... the country’s lower costs and various other advantages. Moreover, many domestic pharmaceutical companies as well have increased their R&D spending for new drug development and are outsourcing clinical trials to various CROs. With this rapid ...  |  read more...

... the number of cancer patients in the country. The Anti-cancer Drugs market in Japan has also been witnessing the trend of using a combination of cancer therapies for treatment. However, stringent government regulations in Japan ...  |  read more...

... analyses major bio-pharmaceutical market segments, top therapeutic categories and traditional medicine market (herbal drugs, ayurvedic and homeopathy). Report also include SWOT analysis, major driving forces, industry growth barriers, Opportunities, Regulatory structure, Macro economy factors and ...  |  read more...

... Paper provides a brief look at Outsourcing in Brazil, Russia, China and India.  It is based on the information in our report.  Outsourcing in Drug Development: The Clinical Trial, CRO Market, available from Kalorama Information.  |  read more...

... statistics, and treatment challenges. Along with this coverage, the research service also outlines market drivers and restraints, market engineering measurements, and market trends. The research service ends with a market analysis, which includes the competitive ...  |  read more...

... even sub-segments of the industry. The report also discusses the trends, development, growth drivers, M&A’s and future expected performance of the industry. The report also entails market share of major players and their performance on ...  |  read more...

... offshoring and outsourcing destinations. Features and benefits Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity. Analyze how clinical trial numbers are changing in China, India, ...  |  read more...

... known factors including obesity, aging population and growth, and increasing Western diets and lifestyles. Large hypertensive populations will lead to more cardiovascular-related diseases and co-morbidities. Introduction Gain insight to market potential, including a robust 10-year ...  |  read more...

... portfolios, pipelines, strategies and local deals of both domestic and multinational vaccine companies and suggests strategies for optimal market penetration. Introduction Review the current regulatory process, pricing, vaccination recommendations and coverage in China. Examine the ...  |  read more...